Sentinel lymph node biopsy in breast cancer: Predictors of axillary and non-sentinel lymph node involvement

Basit Öğe Kaydı
dc.contributor.authorPostaci H.
dc.contributor.authorZengel B.
dc.contributor.authorYararbaş U.
dc.contributor.authorUslu A.
dc.contributor.authorEliyatkin N.
dc.contributor.authorAkpinar G.
dc.contributor.authorCengiz F.
dc.contributor.authorDurusoy R.
dc.date.accessioned2019-10-27T08:24:12Z
dc.date.available2019-10-27T08:24:12Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description.abstractBackground: Sentinel lymph node biopsy is a standard method for the evaluation of axillary status in patients with T1-2N0M0 breast cancers. Aims: To determine the prognostic significance of primary tumour-related clinico-histopathological factors on axillary and non-sentinel lymph node involvement of patients who underwent sentinel lymph node biopsy. Study design: Retrospective clinical study. Methods: In the present study, 157 sentinel lymph node biopsies were performed in 151 consecutive patients with early stage breast cancer between June 2008 and December 2011. Results: Successful lymphatic mapping was obtained in 157 of 158 procedures (99.4%). The incidence of larger tumour size (2.543±1.21 vs. 1.974±1.04), lymphatic vessel invasion (70.6% vs. 29.4%), blood vessel invasion (84.2% vs. 15.8%), and invasive lobular carcinoma subtype (72.7% vs. 27.3%) were statistically significantly higher in patients with positive SLNs. Logistic stepwise regression analysis disclosed tumour size (odds ratio: 1.51, p=0.0021) and lymphatic vessel invasion (odds ratio: 4.68, p=0.001) as significant primary tumour-related prognostic determinants of SLN metastasis. Conclusion: A close relationship was identified between tumour size and lymphatic vessel invasion of the primary tumour and axillary lymph node involvement. However, the positive predictive value of these two independent variables is low and there is no compelling evidence to recommend their use in routine clinical practice. © Trakya University Faculty of Medicine.en_US
dc.identifier.doi10.5152/balkanmedj.2013.9591
dc.identifier.endpage421en_US
dc.identifier.issn2146-3123
dc.identifier.issn2146-3123en_US
dc.identifier.issue4en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage415en_US
dc.identifier.urihttps://doi.org/10.5152/balkanmedj.2013.9591
dc.identifier.urihttps://hdl.handle.net/11454/26546
dc.identifier.volume30en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherGalenos Publishing Houseen_US
dc.relation.ispartofBalkan Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBreast neoplasmsen_US
dc.subjectLymphatic metastasisen_US
dc.subjectSentinel lymph node biopsyen_US
dc.titleSentinel lymph node biopsy in breast cancer: Predictors of axillary and non-sentinel lymph node involvementen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu